Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes.

Ingelfinger JR. Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes. N Engl J Med. 2011 Mar 10; 364(10):970-1.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.